Syndicated Research Studies

Get ready for a healthcare revolution right at home! The U.S. home infusion therapy market is set to reach an impressive USD 31.8 billion by 2030, expanding at a strong CAGR of 7.7% from 2024 to 2030. This significant growth is being driven by a confluence of factors, making in-home care a cornerstone of modern medicine. Why Home is Where the Healing Is The primary engines behind this market surge include a rapidly expanding geriatric population and a growing prevalence of chronic conditions. We're talking about a spectrum of disorders like cancer, immune deficiencies, Crohn's disease, various infections, dehydration, nutritional deficiencies, multiple sclerosis, and even nausea and vomiting. As the need to reduce lengthy hospital stays becomes more pressing, especially for an aging demographic, home infusion therapy offers a crucial alternative. Another major catalyst is the alarming rise of Hospital-Acquired Infections (HAIs). According to the U.S. Centers for Disease Con...

U.S. Home Infusion Therapy Industry Overview The U.S. home infusion therapy market size was estimated at USD 16.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030. The growing elderly population prone to various severe disorders is one of the major drivers for the market growth. The growing geriatric population and increasing prevalence of cancer, Crohn's disease, multiple sclerosis, nutritional and immune deficiencies, infections, dehydration, and nausea & vomiting are majorly driving the growth. The COVID-19 outbreak increased the importance and demand for medical devices especially in a home-based setting as the virus is transmitted through physical contact. The market witnessed revenue growth in 2020, but the key players faced supply chain bottlenecks. However, in 2021, key players like Baxter, Option Healthcare, and Smiths Medical reported a soaring revenue increase as compared to 2020, especially in the U.S. Fo...